Resistance to antifungal drugs is an increasing issue in treating disease caused by the fungal pathogen Candida albicans. As a step towards new antifungal approaches, we investigated antifungal delivery of molecules to C. albicans cells using the cell-penetrating peptide, MPG, genetically fused to the model cargo, green fluorescent protein (GFP). We varied the orientation of the fusion of GFP to MPG and evaluated translocation into the cells. We found fusing the GFP to the C-terminus of the peptide resulted in translocation into almost 5% of C. albicans cells, while fusion of GFP to the N-terminus of the peptide resulted in translocation into less than 0.3% of cells. Our results indicate that fusion of cargo to the C-terminus of MPG is pref...
Candida albicans is an opportunistic fungal pathogen that may cause mucutaneous infection and/or dis...
Invasive fungal infections have a devastating impact on human health worldwide, in part due to the l...
Discovery of new antifungal chemo-therapeutics for humans is limited by the large degree of conserva...
Recombinant production of cell-penetrating peptides (CPPs) as fusions to protein “cargo” leads to lo...
Fungal infections caused by Candida albicans pose a serious threat to public health. The rising drug...
Fungal infections caused by Candida species, particularly C. albicans and C. glabrata, have become a...
The salivary peptide histatin 5 has been studied as a novel therapeutic to address rising drug resis...
Candida albicans (C. albicans) is an opportunistic fungal pathogen, which causes superficial to syst...
The aim of this project was to investigate the possible role of the biofilm matrix as a barrier to d...
Candida albicans is an opportunistic pathogen that can cause infections that range from mild rashes ...
International audience: There is increasing interest in drug delivery systems, such as nanoparticles...
ACKNOWLEDGMENTS We gratefully acknowledge Kevin McKenzie and Lucy Wight from the University of Aberd...
Fungal infections with increasing resistance to conventional therapies are a growing concern. Candid...
Candida albicans is an important cause of systemic infections in the immune compromised population. ...
Candida albicans is the most important fungal species associated with humans. Normally present in th...
Candida albicans is an opportunistic fungal pathogen that may cause mucutaneous infection and/or dis...
Invasive fungal infections have a devastating impact on human health worldwide, in part due to the l...
Discovery of new antifungal chemo-therapeutics for humans is limited by the large degree of conserva...
Recombinant production of cell-penetrating peptides (CPPs) as fusions to protein “cargo” leads to lo...
Fungal infections caused by Candida albicans pose a serious threat to public health. The rising drug...
Fungal infections caused by Candida species, particularly C. albicans and C. glabrata, have become a...
The salivary peptide histatin 5 has been studied as a novel therapeutic to address rising drug resis...
Candida albicans (C. albicans) is an opportunistic fungal pathogen, which causes superficial to syst...
The aim of this project was to investigate the possible role of the biofilm matrix as a barrier to d...
Candida albicans is an opportunistic pathogen that can cause infections that range from mild rashes ...
International audience: There is increasing interest in drug delivery systems, such as nanoparticles...
ACKNOWLEDGMENTS We gratefully acknowledge Kevin McKenzie and Lucy Wight from the University of Aberd...
Fungal infections with increasing resistance to conventional therapies are a growing concern. Candid...
Candida albicans is an important cause of systemic infections in the immune compromised population. ...
Candida albicans is the most important fungal species associated with humans. Normally present in th...
Candida albicans is an opportunistic fungal pathogen that may cause mucutaneous infection and/or dis...
Invasive fungal infections have a devastating impact on human health worldwide, in part due to the l...
Discovery of new antifungal chemo-therapeutics for humans is limited by the large degree of conserva...